Current Study: D7

Purpose:

• To determine how the investigational drug is broken down and removed from the body in volunteers with liver impairment when compared to volunteers with normal liver function
• Information regarding safety and side effects that may occur will also be collected
• This study is for research purposes only and is not intended to treat your liver disease

Method of Administration: Single oral dose of study medication

Investigator: Thomas Marbury, MD

To qualify:

• 18 to 75 years old
• Must have decreased liver function or disease such as fatty liver disease, Hepatitis C, or past history of alcohol related liver disease
• Volunteers may be taking medicines such as spironolactone, Lasix®, lactulose, Aldactone®, or rifaximin
• May also have fluid in your abdomen, cirrhosis, or encephalopathy (brain condition that causes irritability or trouble sleeping)

Length/Duration:
• 1 eligibility screening visit
• 15 days and 14 nights in our research facility

Location: 5055 South Orange Avenue, Orlando, FL 32809

Compensation: Qualified participants will receive study medication, study related physical exams and laboratory tests

Qualified study participants will be compensated up to $5,150 for time and travel

Whom to Contact: Recruitment Department: 407-240-7876